The Company’s significant accounting policies are disclosed in the audited financial statements and the notes thereto, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on March 11, 2026. Since the date of those audited financial statements, there have been no material changes to the Company’s significant accounting policies.

Net loss per share attributable to common stockholders

Basic net loss per common share attributable to common stockholders is calculated by dividing the net loss by the weighted-average number of common shares outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share attributable to common stockholders’ calculation, common stock options, restricted stock units, performance stock units and common stock warrants are considered to be potentially dilutive securities. As the Company has reported a net loss for the periods presented, basic and diluted net loss per share attributable to common stockholders is the same as all potentially dilutive securities would have an anti-dilutive impact.

The following table presents the calculation of basic and diluted net loss per share for the three and six months ended June 30, 2026 and 2025 (in thousands, except share and per share data):


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net loss	$	(13,953	)	$	(10,386	)	$	(24,603	)	$	(28,562	)
Denominator:
Weighted-average shares of Series A and Series B common stock outstanding, basic and diluted		53,114,533			32,195,366			42,893,900			32,195,355
Net loss per share of Series A and Series B common stock outstanding, basic and diluted	$	(0.26	)	$	(0.32	)	$	(0.57	)	$	(0.89	)

The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of Series A and Series B common stock outstanding, as their effect would have been anti-dilutive:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Options to purchase Series A common stock		7,570,930		5,738,868		7,570,930		5,738,868
Warrants to purchase Series A common stock		1,000		1,000		1,000		1,000
Restricted stock units		1,127,109		1,098,399		1,127,109		1,098,399
Performance stock units		616,800		—		616,800		—
Total		9,315,839		6,838,267		9,315,839		6,838,267